Todd C. Davis - 13 Dec 2024 Form 4 Insider Report for PALVELLA THERAPEUTICS, INC. (PVLA)

Role
Director
Signature
Kathleen A. McGowan, Attorney-in-Fact
Issuer symbol
PVLA
Transactions as of
13 Dec 2024
Transactions value $
$0
Form type
4
Filing time
17 Dec 2024, 20:44:40 UTC
Previous filing
15 Nov 2024
Next filing
19 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PVLA Stock Option (right to buy) Award $0 +24.7K $0.00 24.7K 13 Dec 2024 Common Stock 24.7K $13.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options will vest and become exercisable in 36 equal monthly installments through the third anniversary of the grant date.